Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 322-327

  Zhang, Tao ^a   Shu, Hai Hua ^b   Chang, Lu ^a   Ye, Fang ^a   Xu, Kang Qing ^a   Huang, Wen Qi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Hepatic ischemia reperfusion; Inflammation; Resolvin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 6; LIVER PROTECTIVE AGENT; MYELOPEROXIDASE; PROTEIN KINASE B; RESOLVIN D1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; LIPOXIN A(4) RECEPTOR, RAT; LIPOXIN RECEPTOR; MESSENGER RNA; PEROXIDASE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HISTOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER LOBE; LIVER PROTECTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; BLOOD; DRUG EFFECTS; GENETICS; LIVER; LIVER DISEASES; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; DOCOSAHEXAENOIC ACIDS; INTERLEUKIN-6; LIVER; LIVER DISEASES; MALE; PEROXIDASE; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; RECEPTORS, LIPOXIN; REPERFUSION INJURY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84933531959     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.06.017     Document Type: Article

References (30)

1. E.E. Montalvo-Jave, T. Escalante-Tattersfield, J.A. Ortega-Salgado, E. Pina, and D.A. Geller Factors in the pathophysiology of the liver ischemia-reperfusion injury J. Surg. Res. 147 2008 153 159
2. T.K. Howard, G.B. Klintmalm, J.B. Cofer, B.S. Husberg, R.M. Goldstein, and T.A. Gonwa The influence of preservation injury on rejection in the hepatic transplant recipient Transplantation 49 1990 103 107
3. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat. Rev. Immunol. 8 2008 349 361
4. A. Recchiuti Resolvin D1 and its GPCRs in resolution circuits of inflammation Prostaglandins Other Lipid Mediat. 107 2013 64 76
5. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, and R. Yang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc. Natl. Acad. Sci. U. S. A. 107 4 Jan 26 2010 1660 1665
6. Z.Z. Xu, L. Zhang, T. Liu, J.Y. Park, T. Berta, and R. Yang Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions Nat. Med. 16 5 May 2010 592 597 (1p following 597)
7. S. Bang, S. Yoo, T.J. Yang, H. Cho, Y.G. Kim, and S.W. Hwang Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception Br. J. Pharmacol. 161 2010 707 720
8. J.F. Lima-Garcia, R.C. Dutra, K. da Silva, E.M. Motta, M.M. Campos, and J.B. Calixto The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats Br. J. Pharmacol. 164 2 Sep 2011 278 293
9. Y. Tang, M.J. Zhang, J. Hellmann, M. Kosuri, A. Bhatnagar, and M. Spite Proresolution therapy for the treatment of delayed healing of diabetic wounds Diabetes 62 2 Feb 2013 618 627
10. J.S. Duffield, S. Hong, V.S. Vaidya, Y. Lu, G. Fredman, and C.N. Serhan Resolvin D series and protectin D1 mitigate acute kidney injury J. Immunol. 177 9 Nov 1 2006 5902 5911
11. F. Chen, X.H. Fan, Y.P. Wu, J.L. Zhu, F. Wang, and L.L. Bo Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response Eur. J. Clin. Microbiol. Infect. Dis. 33 3 Mar 2014 457 464
12. H. Cimarosti, L.L. Zamin, R. Frozza, M. Nassif, A.P. Horn, and A. Tavares Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3beta Neurochem. Res. 30 2005 191 199
13. T. Nishimoto, T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3beta J. Neurosci. Res. 86 2008 1096 1105
14. C. Muller, F. Dunschede, E. Koch, A.M. Vollmar, and A.K. Kiemer Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G769 G778
15. K. Izuishi, M. Fujiwara, M.A. Hossain, H. Usuki, and H. Maeta Significance of phosphoinositide 3-kinase pathway on ischemic preconditioning followed by ischemia reperfusion in mice liver Transplant. Proc. 35 2003 132 133
16. O. Odusanwo, S. Chinthamani, A. McCall, M.E. Duffey, and O.J. Baker Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation Am. J. Physiol. Cell Physiol. 302 9 May 1 2012 C1331 C1345
17. Q. Wang, X. Zheng, Y. Cheng, Y.L. Zhang, H.X. Wen, and Z. Tao Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na, K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury J. Immunol. 192 8 Apr 15 2014 3765 3777
18. B.H. Heijnen, I.H. Straatsburg, D.J. Gouma, and T.M. van Gulik Decrease in core liver temperature with 10 degrees C by in situ hypothermic perfusion under total hepatic vascular exclusion reduces liver ischemia and reperfusion injury during partial hepatectomy in pigs Surgery 134 2003 806 817
19. G.A. Wanner, W. Ertel, P. Müller, Y. Höfer, R. Leiderer, and M.D. Menger Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation Shock 5 1 Jan 1996 34 40
20. L.M. Colletti, D.G. Remick, G.D. Burtch, S.L. Kunkel, R.M. Strieter, and D.A. Campbell Jr. Role of tumor necrosis factor-a in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat J. Clin. Invest. 85 1990 1936 1943
21. L.M. Colletti, S.L. Kunkel, A. Walz, M.D. Burdick, R.G. Kunkel, and C.A. Wilke The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat Hepatology 23 1996 506 514
22. R.E. Banks, M.A. Forbes, M. Storr, J. Higginson, D. Thompson, J. Raynes, J.M. Illingworth, T.J. Perren, P.J. Selby, and J.T. Whicher The acute phase protein response in patients receiving subcutaneous IL-6 Clin. Exp. Immunol. 102 1 Oct 1995 217 223
23. T. Wüstefeld, T. Rakemann, S. Kubicka, M.P. Manns, and C. Trautwein Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice Hepatology 32 2000 514 522
24. W. Yaxin, Y. Shanglong, S. Huaqing, L. Hong, Y. Shiying, and C. Xiangdong Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway J. Surg. Res. 188 1 May 1 2014 213 221
25. R. Settimio, D.F. Clara, F. Franca, S. Francesca, and D. Michele Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis Mediators Inflamm. 2012 2012 318621
26. S. Fiore, J.F. Maddox, H.D. Perez, and C.N. Serhan Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor J. Exp. Med. 180 1994 253 260
27. T. Takano, S. Fiore, J.F. Maddox, H.R. Brady, N.A. Petasis, and C.N. Serhan Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
28. N. Chiang, C.N. Serhan, S.E. Dahlen, J.M. Drazen, D.W. Hay, and G.E. Rovati The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo Pharmacol. Rev. 58 2006 463 487
29. J.K. Frediani, D.P. Jones, N. Tukvadze, K. Uppal, E. Sanikidze, and M. Kipiani Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study PLoS One 9 10 Oct 15 2014 e108854
30. X.W. Zhao, J.J. Bao, C. Hu, H. Ding, X.C. Liu, and Q. Mei Effect of diclofenac on the levels of lipoxin A4 and resolvin D1 and E1 in the post-ERCP pancreatitis Dig. Dis. Sci. 59 12 Dec 2014 2992 2996